The first Pfizer trade was made in Q3 1999.
Since then George Soros bought shares eleven more times and sold shares on fourteen occasions. The investor sold all their shares in Q2 2017 and doesn't own any shares in Pfizer anymore.
Avg closing price
Price range
Sold -31.2 Thousand shares
Q2 2017
Avg closing price
$33.24
Price range
$31.75
-
$34.34
New holding (+31.2 Thousand shares)
Q1 2017
Avg closing price
$33.23
Price range
$31.15
-
$34.63
Sold -165 Thousand shares
Q2 2013
Avg closing price
$29.12
Price range
$27.23
-
$31.08
Sold 69.4% shares (-373 Thousand shares)
Q3 2012
Avg closing price
$23.79
Price range
$22.34
-
$24.96
Sold 32.3% shares (-257 Thousand shares)
Q2 2012
Avg closing price
$22.39
Price range
$21.60
-
$23.08
Increased shares by 3381.2% (+772 Thousand shares)
Q1 2012
Avg closing price
$21.60
Price range
$20.95
-
$22.64
Sold 96.6% shares (-644 Thousand shares)
Q4 2011
Avg closing price
$19.74
Price range
$17.33
-
$21.83
Increased shares by 17.1% (+97.4 Thousand shares)
Q3 2011
Avg closing price
$18.68
Price range
$16.66
-
$20.78
Sold 0.3% shares (-1.6 Thousand shares)
Q2 2011
Avg closing price
$20.58
Price range
$19.79
-
$21.45
Sold 32.9% shares (-280 Thousand shares)
Q1 2011
Avg closing price
$19.09
Price range
$17.68
-
$20.38
Sold 64.8% shares (-1.56 Million shares)
Q4 2010
Avg closing price
$17.17
Price range
$16.30
-
$17.80
Increased shares by 627.3% (+2.08 Million shares)
Q3 2010
Avg closing price
$15.94
Price range
$14.14
-
$17.42
Sold 97.1% shares (-11.2 Million shares)
Q2 2010
Avg closing price
$15.96
Price range
$14.26
-
$17.29
New holding (+11.6 Million shares)
Q4 2009
Avg closing price
$17.77
Price range
$16.15
-
$18.85
Increased shares by 7.2% (+457 shares)
Q2 2005
Avg closing price
-
Price range
-
-
-
Increased shares by 23.0% (+1.19 Thousand shares)
Q1 2005
Avg closing price
-
Price range
-
-
-
New holding (+5.19 Thousand shares)
Q4 2004
Avg closing price
-
Price range
-
-
-
Sold 46.8% shares (-1.32 Million shares)
Q1 2003
Avg closing price
-
Price range
-
-
-
Increased shares by 4523.0% (+2.76 Million shares)
Q4 2002